Evidence map›Paper›PMID 28289872›Full record

ArticleRheumatology international2017

Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features.

Yasemin Kabasakal, Gul Kitapçıoğlu, Gonca Karabulut, Mehmet Tezcan, Ayse Balkarlı, Adem Aksoy, Şule Yavuz, Sema Yılmaz, Timuçin Kaşifoğlu, Umut Kalyoncu and 24 more

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Olfactory dysfunction in primary Sjogren's syndrome and its correlation with dry eye.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2021
    Article
  3. Article
  4. Cutaneous and Mucosal Manifestations of Sjögren's Syndrome.Clinical reviews in allergy & immunology · 2017
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors.

Yasemin KabasakalDepartment of Internal Medicine-Rheumatology, Faculty of Medicine, Ege University, 35040, Izmir, Turkey. yasemin.kabasakal@gmail.com.
Gul KitapçıoğluBiostatistics and Medical Informatics, Ege Üniversitesi Tıp Fakültesi, İzmir, Turkey.
Gonca KarabulutDepartment of Internal Medicine-Rheumatology, Faculty of Medicine, Ege University, 35040, Izmir, Turkey.
Mehmet TezcanRheumatology, Gazi Universitesi Tıp Fakültesi, Ankara, Turkey.
Ayse BalkarlıRheumatology, Pamukkale Universitesi Tıp Fakültesi, Denizli, Turkey.
Adem AksoyRheumatology, Dokuz Eylül Üniversitesi Tıp Fakültesi, İzmir, Turkey.
Şule YavuzRheumatology, Marmara Üniversitesi Tıp Fakültesi, İstanbul, Turkey.
Sema YılmazRheumatology, Selçuk Üniversitesi Tıp Fakültesi, Konya, Turkey.
Timuçin KaşifoğluRheumatology, Eskişehir Osmangazi Üniversitesi Tıp Fakültesi, Eskişehir, Turkey.
Umut KalyoncuRheumatology, Hacettepe Üniversitesi Tıp Fakültesi, Ankara, Turkey.
Ediz DalkılıçRheumatology, Uludağ Üniversitesi Tıp Fakültesi, Bursa, Turkey.
Abdurrahman TufanRheumatology, Gazi Universitesi Tıp Fakültesi, Ankara, Turkey.
Rıdvan MercanRheumatology, Gazi Universitesi Tıp Fakültesi, Ankara, Turkey.
Fatih YıldızRheumatology, Çukurova Üniversitesi Tıp Fakültesi, Adana, Turkey.
Taşkın ŞentürkRheumatology, Adnan Menderes Üniversitesi Tıp Fakültesi, Aydın, Turkey.
Fatoş ÖnenRheumatology, Dokuz Eylül Üniversitesi Tıp Fakültesi, İzmir, Turkey.
Cemal BesRheumatology, Abant İzzet Baysal Üniversitesi Tıp Fakültesi, Bolu, Turkey.
Eren ErkenRheumatology, Çukurova Üniversitesi Tıp Fakültesi, Adana, Turkey.
Ercan TunçRheumatology, Süleyman Demirel Üniversitesi Tıp Fakültesi, Isparta, Turkey.
Sevil KamalıRheumatology, İstanbul Üniversitesi İstanbul Tıp Fakültesi, İstanbul, Turkey.
Emine TarhanRheumatology, İzmir Katip Çelebi Üniversitesi Tıp Fakültesi, İzmir, Turkey.
Ayten YazıcıRheumatology, Kocaeli Üniversitesi Tıp Fakültesi, İzmit, Turkey.
Nurşen DüzgünRheumatology, Ankara Üniversitesi Tıp Fakültesi, Ankara, Turkey.
Müge BıçakçıgilRheumatology, Yeditepe Üniversitesi Tıp Fakültesi, İstanbul, Turkey.
Sedat YılmazRheumatology, Gülhane Askeri Tıp Akademisi, Ankara, Turkey.
Mustafa ÖzmenRheumatology, İzmir Atatürk Eğitim Araştırma Hastanesi, İzmir, Turkey.
Lale ÖcalRheumatology, İstanbul Üniversitesi İstanbul Tıp Fakültesi, İstanbul, Turkey.
Fatma Alibaz-ÖnerRheumatology, Marmara Üniversitesi Tıp Fakültesi, İstanbul, Turkey.
Dilek SolmazRheumatology, Dokuz Eylül Üniversitesi Tıp Fakültesi, İzmir, Turkey.
Veli ÇobankaraRheumatology, Pamukkale Universitesi Tıp Fakültesi, Denizli, Turkey.
Selim NalbantRheumatology, GATA Haydarpaşa Eğitim Hastanesi, İstanbul, Turkey.
Esen Kasapoğlu GünalRheumatology, Maltepe Üniversitesi Tıp Fakültesi, İstanbul, Turkey.
Derya KaşkariRheumatology, Başkent Üniversitesi Tıp Fakültesi, Ankara, Turkey.
Berna GökerRheumatology, Gazi Universitesi Tıp Fakültesi, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with primary Sjogren's syndrome (pSS) may go undiagnosed or be misclassified due to the insidious nature and wide spectrum of the disease. The available several classification criteria emphasize glandular findings. We aimed to analyze the efficiency of various classification criteria sets in patients diagnosed on the clinical basis by expert opinion and to compare those pSS patients who fulfilled these criteria with those who did not. This is a multicenter study in which 834 patients from 22 university-based rheumatology clinics are included. Diagnosis of pSS was made on the clinical basis by the expert opinion. In this study, we only interviewed patients once and collected available data from the medical records. The European criteria, American-European Consensus Group (AECG) and American College of Rheumatology (ACR) Sjogren's criteria were applied. Majority of the patients were women (F/M was 20/1). The median duration from the first pSS-related symptom to diagnosis was significantly shorter in men (2.5 ± 2.3 vs 4.3 ± 5.9 years) (p = 0 < 0.016). When the European, AECG and ACR Sjogren's criteria were applied, 666 patients (79.9%) satisfied at least one of them. In total, 539 patients (64.4%) satisfied the European, 439 (52.6%) satisfied the AECG, and 359 (43%) satisfied the ACR criteria. Among the entire group, 250 patients (29.9%) satisfied all and 168 (20.1%) met none of the criteria. The rates of extraglandular organ involvements were not different between patients who met at least one of the criteria sets and those who met none. There is an urgent need for the modification of the pSS criteria sets to prevent exclusion of patients with extraglandular involvements as the dominant clinical features.

Indexed as

Symptom AssessmentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRheumatologySjogren's SyndromeYoung AdultClassification criteriaEpidemiologyExtraglandular involvementSjogren’s syndrome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.